1. Home
  2. ARDX vs JQC Comparison

ARDX vs JQC Comparison

Compare ARDX & JQC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • JQC
  • Stock Information
  • Founded
  • ARDX 2007
  • JQC 2003
  • Country
  • ARDX United States
  • JQC United States
  • Employees
  • ARDX N/A
  • JQC N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • JQC Finance Companies
  • Sector
  • ARDX Health Care
  • JQC Finance
  • Exchange
  • ARDX Nasdaq
  • JQC Nasdaq
  • Market Cap
  • ARDX 882.9M
  • JQC 747.1M
  • IPO Year
  • ARDX 2014
  • JQC N/A
  • Fundamental
  • Price
  • ARDX $4.29
  • JQC $5.51
  • Analyst Decision
  • ARDX Strong Buy
  • JQC
  • Analyst Count
  • ARDX 9
  • JQC 0
  • Target Price
  • ARDX $10.17
  • JQC N/A
  • AVG Volume (30 Days)
  • ARDX 4.3M
  • JQC 714.6K
  • Earning Date
  • ARDX 08-04-2025
  • JQC 01-01-0001
  • Dividend Yield
  • ARDX N/A
  • JQC 11.13%
  • EPS Growth
  • ARDX N/A
  • JQC N/A
  • EPS
  • ARDX N/A
  • JQC N/A
  • Revenue
  • ARDX $361,706,000.00
  • JQC N/A
  • Revenue This Year
  • ARDX $11.39
  • JQC N/A
  • Revenue Next Year
  • ARDX $32.84
  • JQC N/A
  • P/E Ratio
  • ARDX N/A
  • JQC N/A
  • Revenue Growth
  • ARDX 127.33
  • JQC N/A
  • 52 Week Low
  • ARDX $3.21
  • JQC $4.82
  • 52 Week High
  • ARDX $7.18
  • JQC $5.65
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 51.49
  • JQC 63.47
  • Support Level
  • ARDX $4.27
  • JQC $5.41
  • Resistance Level
  • ARDX $4.48
  • JQC $5.52
  • Average True Range (ATR)
  • ARDX 0.19
  • JQC 0.04
  • MACD
  • ARDX -0.03
  • JQC -0.00
  • Stochastic Oscillator
  • ARDX 15.84
  • JQC 79.17

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.

Share on Social Networks: